AFA

Soutien à la Recherche...
Publications scientifiques françaises

Plan du Site
On retrouve l'afa à l'origine de la plupart des travaux français de recherche de ces dernières années. Il y a maintenant de nombreuses équipes de chercheurs en France travaillant sur les maladies inflammatoires chroniques de l'intestin. On trouvera, ci-dessous, une sélection d'articles publiés et accessibles depuis Internet, sélection très incomplète faite aux détours de recherches d'information (si vous avez des suggestions intéressantes, n'hésitez pas à m'en parler et m'indiquer leurs références).
*

RetourPublications d'équipes de recherche françaises sur le Web :

  1. Severe ulcerative colitis: present medical treatment strategies. Baudet A, Rahmi G, Bretagne AL, Gloro R, Justum AM, Reimund JM. Expert Opin Pharmacother. 2008 Feb;9(3):447-57.  [PubMed - in process]
  2. Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease. Phelip JM, Ducros V, Faucheron JL, Flourie B, Roblin X. Inflamm Bowel Dis. 2008 Feb;14(2):242-8.
  3. Indeterminate colitis: A review of the concept - What's in a name? Geboes K, Colombel JF, Greenstein A, Jewell DP, Sandborn WJ, Vatn MH, Warren B, Riddell RH; The Pathology Task Force of the International Organization of Inflammatory Bowel Diseases (IOIBD; K.G., D.P.J, B.W., R.H.R.). Inflamm Bowel Dis. 2008 Jan 22; [Epub ahead of print]
  4. Capsule endoscopy : recent developments. Galmiche JP, Coron E, Sacher-Huvelin S. Gut. 2008 Jan 21; [Epub ahead of print]
  5. The forgotten role of lymphangitis in Crohn's disease. Van Kruiningen HJ, Colombel JF. Gut. 2008 Jan;57(1):1-4.
  6. Opportunistic infections attributed to immunomodulator agents and tumour necrosis factor antagonists in patients with inflammatory bowel disease: prevention and diagnosis. Viget N, Vernier-Massouille G, Salmon-Céron D, Yazdanpanah Y, Colombel JF.Gut. 2008 Jan 4; [Epub ahead of print]
  7. Aplasie médullaire fébrile après deux injections de méthotrexate chez un malade atteint de rectocolite hémorragique. Chalumeau S, Moussata D, Nancey S, Claudel-Bonvoisin S, Saurin JC, Flourié B. Gastroenterol Clin Biol. 2007 Dec;31(12):1104-6. French.
  8. Incidence of inflammatory bowel disease in Corsica from 2002 to 2003. Abakar-Mahamat A, Filippi J, Pradier C, Dozol A, Hébuterne X. Gastroenterol Clin Biol. 2007 Dec;31(12):1098-103.
  9. The 10 Remaining Mysteries of Inflammatory Bowel Disease. Colombel JF, Watson AJ, Neurath MF. Gut. 2007 Dec 13; [Epub ahead of print]
  10. Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation. Thibault R, De Coppet P, Daly K, Bourreille A, Cuff M, Bonnet C, Mosnier JF, Galmiche JP, Shirazi-Beechey S, Segain JP. Gastroenterology. 2007 Dec;133(6):1916-27.
  11. Different effects of the Cdx1 and Cdx2 homeobox genes in a murine model of intestinal inflammation. Calon A, Gross I, Lhermitte B, Martin E, Beck F, Duclos B, Kedinger M, Duluc I, Domon-Dell C, Freund JN. Gut. 2007 Dec;56(12):1688-95.
  12. IBD serological panels: facts and perspectives. Peyrin-Biroulet L, Standaert-Vitse A, Branche J, Chamaillard M. Inflamm Bowel Dis. 2007 Dec;13(12):1561-6.
  13. Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy. Sellam J, Hamdi H, Roy C, Baron G, Lemann M, Puéchal X, Breban M, Berenbaum F, Humbert M, Weldingh K, Salmon D, Ravaud P, Emilie D, Mariette X; RATIO (Research Axed on Tolerance of Biotherapies) Study Group. Ann Rheum Dis. 2007 Dec;66(12):1610-5.
  14. Detection of Antisynthetic Mannoside Antibodies (ASigmaMA) Reveals Heterogeneity in the ASCA Response of Crohn's Disease Patients and Contributes to Differential Diagnosis, Stratification, and Prediction. Vandewalle-El Khoury P, Colombel JF, Joossens S, Standaert-Vitse A, Collot M, Halfvarson J, Ayadi A, Landers CJ, Vermeire S, Rutgeerts P, Targan SR, Chamaillard M, Mallet JM, Sendid B, Poulain D. Am J Gastroenterol. 2007 Nov 28; [Epub ahead of print]
  15. Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis. Cacheux W, Seksik P, Lemann M, Marteau P, Nion-Larmurier I, Afchain P, Daniel F, Beaugerie L, Cosnes J. Am J Gastroenterol. 2007 Nov 28; [Epub ahead of print]
  16. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis. Bossard C, Denis MG, Bézieau S, Bach-Ngohou K, Bourreille A, Laboisse CL, Mosnier JF. Oncol Rep. 2007 Nov;18(5):1093-7.
  17. Cluster of Crohn's disease in Herny, France, including 2 cases from a common residence. Van Kruiningen HJ, Joossens M, Colombel JF. Inflamm Bowel Dis. 2007 Nov;13(11):1454-5. No abstract available.
  18. Inflammatory bowel diseases: the paediatric gastroenterologist's perspective. Hugot JP, Bellaiche M. Pediatr Radiol. 2007 Nov;37(11):1065-70.
  19. Restoration of soluble CD146 in patients with Crohn's disease treated with the TNF-alpha antagonist infliximab. Reumaux D, Bardin N, Colombel JF, Dignat-George F, Duthilleul P, Vermeire S.Inflamm Bowel Dis. 2007 Oct;13(10):1315-7. No abstract available.
  20. A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease. Abitbol V, Briot K, Roux C, Roy C, Seksik P, Charachon A, Bouhnik Y, Coffin B, Allez M, Lamarque D, Chaussade S. Clin Gastroenterol Hepatol. 2007 Oct;5(10):1184-9.
  21. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability. Svrcek M, El-Bchiri J, Chalastanis A, Capel E, Dumont S, Buhard O, Oliveira C, Seruca R, Bossard C, Mosnier JF, Berger F, Leteurtre E, Lavergne-Slove A, Chenard MP, Hamelin R, Cosnes J, Beaugerie L, Tiret E, Duval A, Fléjou JF. J Clin Oncol. 2007 Sep 20;25(27):4231-8.
  22. Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis. Reinisch W, Sandborn WJ, Bala M, Yan S, Feagan BG, Rutgeerts P, Radford-Smith G, Xu S, Eisenberg D, Olson A, Colombel JF. Inflamm Bowel Dis. 2007 Sep;13(9):1135-40.
  23. Search for evidence of recurring or persistent viruses in Crohn's disease. Van Kruiningen HJ, Poulin M, Garmendia AE, Desreumaux P, Colombel JF, De Hertogh G, Geboes K, Vermeire S, Tsongalis GJ. APMIS. 2007 Aug;115(8):962-8.
  24. LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease. Coste A, Dubuquoy L, Barnouin R, Annicotte JS, Magnier B, Notti M, Corazza N, Antal MC, Metzger D, Desreumaux P, Brunner T, Auwerx J, Schoonjans K. Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13098-103.
  25. Ganglioneuromatosis: an unusual cause of ileal stricture mimicking Crohn's disease. Lorenceau-Savale C, Savoye G, Pouzoulet J, Le Pessot F, Savoye-Collet C, Leblanc-Louvry I, Lerebours E. Dig Dis Sci. 2007 Aug;52(8):1806-9.
  26. Estimating the odds ratios of Crohn disease for the main CARD15/NOD2 mutations using a conditional maximum likelihood method in pedigrees collected via affected family members. Pascoe L, Zouali H, Sahbatou M, Hugot JP. Eur J Hum Genet. 2007 Aug;15(8):864-71.
  27. American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Clark M, Colombel JF, Feagan BC, Fedorak RN, Hanauer SB, Kamm MA, Mayer L, Regueiro C, Rutgeerts P, Sandborn WJ, Sands BE, Schreiber S, Targan S, Travis S, Vermeire S. Gastroenterology. 2007 Jul;133(1):312-39.
  28. Familial Crohn's disease in Belgium: pedigrees, temporal relationships among cases, and family histories. Van Kruiningen HJ, Joossens M, Vermeire S, Joossens S, Debeugny S, Gower-Rousseau C, Cortot A, Colombel JF, Rutgeerts P, Vlietinck R. J Clin Gastroenterol. 2007 Jul;41(6):583-90.
  29. Antimycobacterial therapy in Crohn's disease: game over?. Peyrin-Biroulet L, Neut C, Colombel JF. Gastroenterology. 2007 Jun;132(7):2594-8. Review. No abstract available.
  30. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Allez M, Tieng V, Nakazawa A, Treton X, Pacault V, Dulphy N, Caillat-Zucman S, Paul P, Gornet JM, Douay C, Ravet S, Tamouza R, Charron D, Lémann M, Mayer L, Toubert A. Gastroenterology. 2007 Jun;132(7):2346-58.
  31. Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial. Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Colombel JF, Panaccione R, D'Haens G, Li J, Rosenfeld MR, Kent JD, Pollack PF. Ann Intern Med. 2007 Jun 19;146(12):829-38.
  32. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Hugot JP, Zaccaria I, Cavanaugh J, Yang H, Vermeire S, Lappalainen M, Schreiber S, Annese V, Jewell DP, Fowler EV, Brant SR, Silverberg MS, Cho J, Rioux JD, Satsangi J, Parkes M; for the IBD International Genetics Consortium. Am J Gastroenterol. 2007 Jun;102(6):1259-67.
  33. Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis. Vasquez N, Mangin I, Lepage P, Seksik P, Duong JP, Blum S, Schiffrin E, Suau A, Allez M, Vernier G, Tréton X, Doré J, Marteau P, Pochart P. Inflamm Bowel Dis. 2007 Jun;13(6):684-92.
  34. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, Allez M, Peeters H, Bommelaer G, Desreumaux P, Colombel JF, Darfeuille-Michaud A. J Clin Invest. 2007 Jun;117(6):1566-74.
  35. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.  Hugot JP, Zaccaria I, Cavanaugh J, Yang H, Vermeire S, Lappalainen M, Schreiber S, Annese V, Jewell DP, Fowler EV, Brant SR, Silverberg MS, Cho J, Rioux JD, Satsangi J, Parkes M; for the IBD International Genetics Consortium. Am J Gastroenterol. 2007 Jun;102(6):1259-67.
  36. Appendectomy, smoking habits and the risk of developing ulcerative colitis: a case control study in private practice setting. De Saussure P, Clerson P, Prost PL, Truong Tan N, Bouhnik Y, Gil-Rch. Gastroenterol Clin Biol. 2007 May;31(5):493-7.
  37. Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature. André MF, Piette JC, Kémény JL, Ninet J, Jego P, Delèvaux I, Wechsler B, Weiller PJ, Francès C, Blétry O, Wismans PJ, Rousset H, Colombel JF, Aumaître O; French Study Group on Aseptic Abscesses. Medicine (Baltimore). 2007 May;86(3):145-61. Review.
  38. Laparoscopic subtotal colectomy for acute or severe colitis complicating inflammatory bowel disease: a case-matched study in 88 patients. Marceau C, Alves A, Ouaissi M, Bouhnik Y, Valleur P, Panis Y. Surgery. 2007 May;141(5):640-4.
  39. Bevacizumab and postponed suture leakages after surgery for ulcerative colitis and rectal cancer. Adenis A, Vanseymortier L, Foissey D, Colombel JF. Gut. 2007 May;56(5):734. No abstract available.
  40. The NOD2-RICK complex signals from the plasma membrane. Lécine P, Esmiol S, Métais JY, Nicoletti C, Nourry C, McDonald C, Nunez G, Hugot JP, Borg JP, Ollendorff V. J Biol Chem. 2007 May 18;282(20):15197-207.
  41. Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine. Peyrin-Biroulet L, Rodriguez-Guéant RM, Chamaillard M, Desreumaux P, Xia B, Bronowicki JP, Bigard MA, Guéant JL. Am J Gastroenterol. 2007 May;102(5):1108-15. Review.
  42. Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro. Meconi S, Vercellone A, Levillain F, Payré B, Al Saati T, Capilla F, Desreumaux P, Darfeuille-Michaud A, Altare F. Cell Microbiol. 2007 May;9(5):1252-61.
  43. Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro. Meconi S, Vercellone A, Levillain F, Payré B, Al Saati T, Capilla F, Desreumaux P, Darfeuille-Michaud A, Altare F. Meconi S, Vercellone A, Levillain F, Payré B, Al Saati T, Capilla F, Desreumaux P, Darfeuille-Michaud A, Altare F.
  44. Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study. Peyrin-Biroulet L, Laclotte C, Roblin X, Bigard MA. World J Gastroenterol. 2007 Apr 28;13(16):2328-32.
  45. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study. Desplat-Jégo S, Johanet C, Escande A, Goetz J, Fabien N, Olsson N, Ballot E, Sarles J, Baudon JJ, Grimaud JC, Veyrac M, Chamouard P, Humbel RL. World J Gastroenterol. 2007 Apr 28;13(16):2312-8.
  46. Prise en charge d'une rectocolite hémorragique sévère ou corticorésistante. Carbonnel F. Gastroenterol Clin Biol. 2007 Apr;31(4):398-403. Review. French. No abstract available.
  47. Sténose iléale. Treton X, Stefanescu C, Attar A, Alves A, Zappa M, Bouhnik Y. Gastroenterol Clin Biol. 2007 Apr;31(4):387-92. Review. French. No abstract available.
  48. How NOD2 mutations predispose to Crohn's disease? Vignal C, Singer E, Peyrin-Biroulet L, Desreumaux P, Chamaillard M. Microbes Infect. 2007 Apr;9(5):658-63. Review.
  49. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?. Peyrin-Biroulet L, Chamaillard M, Gonzalez F, Beclin E, Decourcelle C, Antunes L, Gay J, Neut C, Colombel JF, Desreumaux P. Gut. 2007 Apr;56(4):577-83. Review. No abstract available.
  50. Le cytomégalovirus et les maladies inflammatoires cryptogénétiques de l'intestin. Pofelski J, Heluwaert F, Roblin X, Morand P, Gratacap B, Germain E, Brion JP, Salon C, Bonaz B. Gastroenterol Clin Biol. 2007 Mar;31(3):292-6. Review. French.
  51. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P. Dis Colon Rectum. 2007 Mar;50(3):331-6
  52. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P, Schölmerich J, Sutherland LR. Gastroenterology. 2007 Feb;132(2):763-86.
  53. Pure ileal Crohn's disease without colonic involvement after a long ileo-colonic anastomosis (Lester Martin Procedure) for Hirschsprung's disease: an argument favoring a specific sensitivity of the ileum in a subset of patients with Crohn's disease. Dray X, Sokol H, Vahedi K, Lavergne-Slove A, Marteau P. Inflamm Bowel Dis. 2007 Feb;13(2):243-4.
  54. Leukocyte scintigraphy compared to intraoperative small bowel enteroscopy and laparotomy findings in Crohn's disease. Almer S, Granerus G, Ström M, Olaison G, Bonnet J, Lémann M, Smedh K, Franzén L, Bertheau P, Cattan P, Rain JD, Modigliani R. Inflamm Bowel Dis. 2007 Feb;13(2):164-74.
  55. Value of wireless capsule endoscopy in patients with indeterminate colitis (inflammatory bowel disease type unclassified). Maunoury V, Savoye G, Bourreille A, Bouhnik Y, Jarry M, Sacher-Huvelin S, Ben Soussan E, Lerebours E, Galmiche JP, Colombel JF. Inflamm Bowel Dis. 2007 Feb;13(2):152-5.
  56. Expression of epidermal growth factor receptor (EGFR) is frequent in inflammatory bowel disease (IBD)-associated intestinal cancer. Svrcek M, Cosnes J, Tiret E, Bennis M, Parc Y, Fléjou JF. Virchows Arch. 2007 Feb;450(2):243-4.
  57. A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease. Teml A, Schwab M, Hommes DW, Almer S, Lukas M, Feichtenschlager T, Florin T, Seiderer J, Petritsch W, Bokemeyer B, Kreisel W, Herrlinger KR, Knoflach P, Bonaz B, Klugmann T, Herfarth H, Pedarnig N, Reinisch W. Wien Klin Wochenschr. 2007;119(17-18):519-26.
  58. Lack of association between CARD15 gene polymorphisms and hidradenitis suppurativa: a pilot study. Nassar D, Hugot JP, Wolkenstein P, Revuz J. Dermatology. 2007;215(4):359. No abstract available.
  59. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease. Peyrin-Biroulet L, Chamaillard M. J Endotoxin Res. 2007;13(3):135-9. Review.
  60. Transient type III atrioventricular block after infliximab infusion in a fistulizing perianal Crohn's disease patient. Sofos S, Savoye G, Ramirez S, Bauer F, Lerebours E. Am J Gastroenterol. 2007 Jan;102(1):217-9.
  61. Entérite ulcéro-hémorragique associée à une rectocolite hémorragique : mise en rémission après traitement par infliximab. Godart B, Beau P, Benchellal Z, Bumsel F, Metman E. Gastroenterol Clin Biol. 2007 Jan;31(1):88-90.
  62. Recto-colite hémorragique et anti-TNFa. Nancey S, Moussata D, Flourié B. Gastroenterol Clin Biol. 2007 Jan;31(1):84-7. Review.
  63. Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis. Daniel F, Loriot MA, Seksik P, Cosnes J, Gornet JM, Lémann M, Fein F, Vernier-Massouille G, De Vos M, Boureille A, Treton X, Flourié B, Roblin X, Louis E, Zerbib F, Beaune P, Marteau P. Inflamm Bowel Dis. 2007 Jan;13(1):19-23.
  64. Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis. Sokol H, Lepage P, Seksik P, Doré J, Marteau P. Gut. 2007 Jan;56(1):152-4.
  65. Stressful life events as a risk factor for inflammatory bowel disease onset: A population-based case-control study. Lerebours E, Gower-Rousseau C, Merle V, Brazier F, Debeugny S, Marti R, Salomez JL, Hellot MF, Dupas JL, Colombel JF, Cortot A, Benichou J. Am J Gastroenterol. 2007 Jan;102(1):122-31.
  66. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Colombel JF, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R, Schreiber S, Byczkowski D, Li J, Kent JD, Pollack PF. Gastroenterology. 2007 Jan;132(1):52-65.

    2006

  67. Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease? Marteau P. Gut. 2006 Dec;55(12):1692-3.
  68. Treatment of ulcerative colitis refractory to steroid therapy by oral microemulsion cyclosporine (Neoral). Weber A, Fein F, Koch S, Dupont-Gossart AC, Mantion G, Heyd B, Carbonnel F. Inflamm Bowel Dis. 2006 Dec;12(12):1131-5.
  69. Polymorphism in IgG Fc receptor gene FCGR3A and response to infliximab in Crohn's disease: a subanalysis of the ACCENT I study. Louis EJ, Watier HE, Schreiber S, Hampe J, Taillard F, Olson A, Thorne N, Zhang H, Colombel JF. Pharmacogenet Genomics. 2006 Dec;16(12):911-4.
  70. Maladie de Crohn révélée par une sténose duodénale. Stratégie chirurgicale. Gonzalez M, Collaud S, Gervaz P, Frossard JL, Morel P. Ann Chir. 2006 Dec;131(10):636-8.
  71. Colon cancer after infliximab therapy for Crohn's disease in a young patient transplanted for primary sclerosing cholangitis. Peyrin-Biroulet L, Bressenot A, Chone L, Denjean P, Boissel P, Bigard MA, Bronowicki JP. Am J Gastroenterol. 2006 Nov;101(11):2664-5.
  72. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study. Uhlen S, Belbouab R, Narebski K, Goulet O, Schmitz J, Cézard JP, Turck D, Ruemmele FM. Inflamm Bowel Dis. 2006 Nov;12(11):1053-7.
  73. "Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop", Begue B, Dumant C, Bambou JC, Beaulieu JF, Chamaillard M, Hugot JP, Goulet O, Schmitz J, Philpott DJ, Cerf-Bensussan N, Ruemmele FM. J Cell Physiol. 2006 Nov;209(2):241-52.
  74. "Muc2-Deficient Mice Spontaneously Develop Colitis, Indicating That Muc2 Is Critical for Colonic Protection", Van der Sluis M, De Koning BAE, De Bruijn ACJM, Velcich A, Meijerink JPP, Van Goudoever JB, Büller HA, Dekker J, Van Seuningen I, Renes IB, Einerhand AWC. Gastroenterology 2006;131:117–129. (accès Gastroenterology - accès adhérents afa pdf)
  75. "Adalimumab Induces and Maintains Clinical Response and Remission in Patients With Active Crohn’s Disease: Results of the CHARM Trial", Colombel J, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Remo P, Schreiber S, Lomax KG, Pollack PF. Gastroenterology. September 2006 (Vol. 131, Issue 3, Page 950)
  76. "Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence", Desreumaux P, Ghosh S. Aliment Pharmacol Ther. 2006 Sep;24 Suppl 1:2-9.
  77. "Infliximab and human immunodeficiency virus infection: Viral load reduction and CD4+ T-cell loss related to apoptosis", Filippi J, Roger PM, Schneider SM, Durant J, Breittmayer JP, Benzaken S, Bernard A, Dellamonica P, Hebuterne X; Groupe d'Etude Nicois Polyvalent en Infectiologie (GENPI). Arch Intern Med. 2006 Sep 18;166(16):1783-4.
  78. "Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?", Peyrin-Biroulet L, Chamaillard M, Gonzalez F, Beclin E, Decourcelle C, Antunes L, Gay J, Neut C, Colombel JF, Desreumaux P. Gut. 2006 Sep 6.
  79. "PPARgamma as a new therapeutic target in inflammatory bowel diseases", Dubuquoy L, Rousseaux C, Thuru X, Peyrin-Biroulet L, Romano O, Chavatte P, Chamaillard M, Desreumaux P. Gut. 2006 Sep;55(9):1341-9.
  80. "Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis", Sokol H, Lepage P, Seksik P, Dore J, Marteau P. J Clin Microbiol. 2006 Sep;44(9):3172-7.
  81. "Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions", Duburque C, Lelong J, Iacob R, Seddik M, Desreumaux P, Fournier C, Wallaert B, Cortot A, Colombel JF. Aliment Pharmacol Ther. 2006 Sep 1;24(5):851-8.
  82. "Impact of inflammation on the duodenal mRNA expression of CYP3A and P-glycoprotein in children with Crohn's disease", Fakhoury M, Lecordier J, Medard Y, Peuchmaur M, Jacqz-Agrain E. Inflamm Bowel Dis. 2006 Aug;12(8):745-9.
  83. "ADAM15 upregulation and interaction with multiple binding partners in inflammatory bowel disease", Mosnier JF, Jarry A, Bou-Hanna C, Denis MG, Merlin D, Laboisse CL. Lab Invest. 2006 Oct;86(10):1064-73. Epub 2006 Aug 7.
  84. "No evidence for an involvement of the p38 and JNK mitogen-activated protein in inflammatory bowel diseases",vMalamut G, Cabane C, Dubuquoy L, Malapel M, Derijard B, Gay J, Tamboli C, Colombel JF, Desreumaux P. Dig Dis Sci. 2006 Aug;51(8):1443-53. Epub 2006 Jul 13.
  85. "A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease", Reinisch W, Hommes DW, Van Assche G, Colombel JF, Gendre JP, Oldenburg B, Teml A, Geboes K, Ding H, Zhang L, Tang M, Cheng M, van Deventer SJ, Rutgeerts P, Pearce T. Gut. 2006 Aug;55(8):1138-44. Epub 2006 Feb 21."A simple biological score for predicting low risk of short-term relapse in Crohn's disease", Consigny Y, Modigliani R, Colombel JF, Dupas JL, Lemann M, Mary JY; Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). Inflamm Bowel Dis. 2006 Jul;12(7):551-7.
  86. "Les facteurs d'environnement dans la maladie de Crohn et la recto-colite hémorragique (tabac et appendicectomie exclus)", Jantchou P, Monnet E, Carbonnel F. Gastroenterol Clin Biol. 2006 Jun-Jul;30(6-7):859-67. (accès Gastroenterol Clin Biol - accès adhérents afa)
  87. "Localisations vulvo-périnéales de la maladie de Crohn : efficacité du métronidazole", Conscience I, Perceau G, Durlach A, Bernard P. Ann Dermatol Venereol. 2006 Jun-Jul;133(6-7):585-7.
  88. "The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications", Satsangi J, Silverberg MS, Vermeire S, Colombel JF. Gut. 2006 Jun;55(6):749-53.
  89. "Maladie de Crohn révélée par une sténose duodénale. Stratégie chirurgicale", Gonzalez M, Collaud S, Gervaz P, Frossard JL, Morel P. Ann Chir. 2006 Jun 27.
  90. "Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate", Laharie D, Zerbib F, Adhoute X, Boue-Lahorgue X, Foucher J, Castera L, Rullier A, Bertet J, Couzigou P, Amouretti M, de Ledinghen V. Aliment Pharmacol Ther. 2006 Jun 1;23(11):1621-8.
  91. "Infliximab : un nouveau traitement actif dans la recto-colite hémorragique  (RCH) et quelques questions en suspens", Rutgeerts P, Sandborn WJ, Fragan BG, Reinisch W, Olson A, Johanns J, et al. N Engl J Med 2005;353:2462-76. (accès Gastroenterol Clin Biol - accès adhérents afa)
  92. "Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease", Standaert-Vitse A, Jouault T, Vandewalle P, Mille C, Seddik M, Sendid B, Mallet JM, Colombel JF, Poulain D. Gastroenterology. 2006 May;130(6):1764-75.
  93. "Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis", Joossens S, Colombel JF, Landers C, Poulain D, Geboes K, Bossuyt X, Targan S, Rutgeerts PJ, Reinisch W. Gut. 2006 May 10;
  94. "Multilocus sequence typing reveals intrafamilial transmission and microevolutions of Candida albicans isolates from the human digestive tract", Bougnoux ME, Diogo D, Francois N, Sendid B, Veirmeire S, Colombel JF, Bouchier C, Van Kruiningen H, d'Enfert C, Poulain D. J Clin Microbiol. 2006 May;44(5):1810-20.
  95. "Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease", Chamouard P, Richert Z, Meyer N, Rahmi G, Baumann R. Clin Gastroenterol Hepatol. 2006 Jul;4(7):882-7. Epub 2006 Apr 19.
  96. "Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis", Mortier PE, Gambiez L, Karoui M, Cortot A, Paris JC, Quandalle P, Colombel JF. Gastroenterol Clin Biol. 2006 Apr;30(4):594-7.
  97. "Quantitative measurement and visual assessment of ileal Crohn's disease activity by CT enterography: correlation with endoscopic severity and C-reactive protein", Colombel JF, Solem CA, Sandborn WJ, Booya F, Loftus EV, Harmsen WS, Zinsmeister AR, Bodily KD, Fletcher JG. Gut. 2006 Apr 28;
  98. "Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial", Lemann M, Mary JY, Duclos B, Veyrac M, Dupas JL, Delchier JC, Laharie D, Moreau J, Cadiot G, Picon L, Bourreille A, Sobahni I, Colombel JF; Groupe d'Etude Therapeutique des Affections Inflammatoires du Tube Digestif (GETAID). Gastroenterology. 2006 Apr;130(4):1054-61.
  99. "Predictors of Crohn's disease", Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Gastroenterology. 2006 Mar;130(3):650-6.
  100. "Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data", Nerich V, Monnet E, Etienne A, Louafi S, Ramee C, Rican S, Weill A, Vallier N, Vanbockstael V, Auleley GR, Allemand H, Carbonnel F. Inflamm Bowel Dis. 2006 Mar;12(3):218-26.
  101. "European evidence based consensus on the diagnosis and management of Crohn's disease: current management", Travis SP, Stange EF, Lemann M, Oresland T, Chowers Y, Forbes A, D'Haens G, Kitis G, Cortot A, Prantera C, Marteau P, Colombel JF, Gionchetti P, Bouhnik Y, Tiret E, Kroesen J, Starlinger M, Mortensen NJ; European Crohn's and Colitis Organisation. Gut. 2006 Mar;55 Suppl 1:i16-35.
  102. "Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial", Schreiber S, Feagan B, D'Haens G, Colombel JF, Geboes K, Yurcov M, Isakov V, Golovenko O, Bernstein CN, Ludwig D, Winter T, Meier U, Yong C, Steffgen J; BIRB 796 Study Group. Clin Gastroenterol Hepatol. 2006 Mar;4(3):325-34.
  103. "Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease", Rutgeerts P, Diamond RH, Bala M, Olson A, Lichtenstein GR, Bao W, Patel K, Wolf DC, Safdi M, Colombel JF, Lashner B, Hanauer SB. Gastrointest Endosc. 2006 Mar;63(3):433-42; quiz 464.
  104. "Prior appendectomy and the phenotype and course of Crohn's disease",Cosnes J, Seksik P, Nion-Larmurier I, Beaugerie L, Gendre JP. World J Gastroenterol. 2006 Feb 28;12(8):1235-42
  105. "Traitements nutritionnels au cours des MICI : où en est-on?", Piquet MA, Gloro R, Justum AM, Reimund JM.Gastroenterol Clin Biol. 2006 Feb;30(2):262-71. (accès Gastroenterol Clin Biol - accès adhérents afa)
  106. "Efficacy of infliximab in Crohn's disease. Results of a retrospective multicenter study with a 15-month follow-up", Poupardin C, Lemann M, Gendre JP, Sabate JM, Marteau P, Chaussade S, Delchier JC, Bouhnik Y, Chaput JC, Poupon R, Soule JC, Benhamou Y, Grange JD, Coffin B. Gastroenterol Clin Biol. 2006 Feb;30(2):247-52. 
  107. "L'imagerie de fluorescence en endoscopie digestive", Mordon S, Maunoury V, Bulois P, Rochon P, Desreumaux P, Colombel JF. Gastroenterol Clin Biol. 2006 Jan;30(1):165-8.
  108. "Recours aux traitements alternatifs et complémentaires dans les MICI : résultats d'une enquête postale", Michaël Bensoussan, Nicolas Jovenin, Bruno Garcia, Luc Vandromme, Damien Jolly, Olivier Bouché, Gérard Thiéfin, Guillaume Cadiot. Gastroenterol Clin Biol 2006 Jan; 30 ; 14-23.
  109. "Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn's disease: a prospective study", Bourreille A, Jarry M, D'Halluin PN, Ben-Soussan E, Maunoury V, Bulois P, Sacher-Huvelin S, Vahedy K, Lerebours E, Heresbach D, Bretagne JF, Colombel JF, Galmiche JP. Gut. 2006 Jul;55(7):978-83. Epub 2006 Jan 9.

    2005

  110. "Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial", Marteau P, Lemann M, Seksik P, Laharie D, Colombel JF, Bouhnik Y, Cadiot G, Soule JC, Bourreille A, Metman E, Lerebours E, Carbonnel F, Dupas JL, Veyrac M, Coffin B, Moreau J, Abitbol V, Blum-Sperisen S, Mary JY. Gut. 2006 Jun;55(6):842-7. Epub 2005 Dec 23.
  111. "Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation", Philippe D, Chakass D, Thuru X, Zerbib P, Tsicopoulos A, Geboes K, Bulois P, Breisse M, Vorng H, Gay J, Colombel JF, Desreumaux P, Chamaillard M. Gut. 2006 Jun;55(6):815-23. Epub 2005 Nov 18.
  112. "Intestinal perforation in Crohn's disease. Factors predictive of surgical resection", Brihier H, Nion-Larmurier I, Afchain P, Tiret E, Beaugerie L, Gendre JP, Cosnes J. Gastroenterol Clin Biol.2005 Nov;29(11):1105-11.
  113. "Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo", Palascak-Juif V, Bouvier AM, Cosnes J, Flourie B, Bouche O, Cadiot G, Lemann M, Bonaz B, Denet C, Marteau P, Gambiez L, Beaugerie L, Faivre J, Carbonnel F. Inflamm Bowel Dis. 2005 Sep;11(9):828-32.
  114. "Incidence des maladies inflammatoires chroniques intestinales aux Antilles françaises (1997-1999)", Edouard A, Paillaud M, Merle S, Orhan C, Chenayer-Panelatti Dagger M; COGEAG. Gastroenterol Clin Biol. 2005 Aug-Sep;29(8-9):779-83.
  115. "Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999)", Auvin S, Molinie F, Gower-Rousseau C, Brazier F, Merle V, Grandbastien B, Marti R, Lerebours E, Dupas JL, Colombel JF, Salomez JL, Cortot A, Turck D. J Pediatr Gastroenterol Nutr. 2005 Jul;41(1):49-55.
  116. "Ileal involvement is age dependent in pediatric Crohn's disease", Meinzer U, Idestrom M, Alberti C, Peuchmaur M, Belarbi N, Bellaiche M, Mougenot JF, Cezard JP, Finkel Y, Hugot JP. Inflamm Bowel Dis. 2005 Jul;11(7):639-44.
  117. "A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146", Middleton J, Americh L, Gayon R, Julien D, Mansat M, Mansat P, Anract P, Cantagrel A, Cattan P, Reimund JM, Aguilar L, Amalric F, Girard JP. J Pathol. 2005 Jul;206(3):260-8.
  118. "A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine", Marc Lémann, Jean-Yves Mary, Jean-Frédéric Colombel, Bernard Duclos, Jean-Claude Soule, Eric Lerebours, Robert Modigliani, Yoram Bouhnik, GETAID. Gastroenterology. June 2005 (Vol. 128, Issue 7, Pages 1812-1818) 
  119. "Is perianal Crohn's disease associated with intestinal fistulization?", Sachar DB, Bodian CA, Goldstein ES, Present DH, Bayless TM, Picco M, van Hogezand RA, Annese V, Schneider J, Korelitz BI, Cosnes J; Task Force on Clinical Phenotyping of the IOIBD. Am J Gastroenterol. 2005 Jul;100(7):1547-9.
  120. [What is inflammatory bowel disease?], Beaugerie L. Rev Prat. 2005 May 15;55(9):943-8.
  121. "Immune activation and nutritional status in adult Crohn's disease patients", Reimund JM, Arondel Y, Escalin G, Finck G, Baumann R, Duclos B. Dig Liver Dis. 2005 Jun;37(6):424-31. Epub 2005 Mar 17.
  122. "Natalizumab Induction and Maintenance Therapy for Crohn's Disease", William J. Sandborn, Jean-Frédéric Colombel, Roberts Enns, Brian G. Feagan, Stephen B. Hanauer, Ian C. Lawrance, Remo Panaccione, Martin Sanders, Stefan Schreiber, Stephan Targan, Sander van Deventer., Ronald Goldblum, Darrin Despain, M.S, Gary S. Hogge, D.V.M., Paul Rutgeerts. N Engl J Med 2005;353:1912-1925,1965-1968.
  123. "Intestinal anti-inflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-g", Rousseaux C, Lefebvre B, Dubuquoy L, Lefebvre P, Romano O, Auwerx J, Metzger D, Wahli W, Desvergne B, Naccari GC, Chavatte P, Farce A, Bulois P, Cortot A, Colombel JF, Desreumaux P. Journal J Exp Med 2005;201(8).
  124. "Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study", S Baron, D Turck, C Leplat, V Merle, C Gower-Rousseau, R Marti, T Yzet, E Lerebours, J-L Dupas, S Debeugny, J-L Salomez, A Cortot, and J-F Colombel. Gut 2005 Feb;54:357-363.
  125. "Traitement des lésions ano-périnéales de la maladie de Crohn", Philippe Godeberge. Gastroenterol Clin Biol. 2005 Feb;29(2):166-77. (accès Gastroenterol Clin Biol - accès adhérents afa)
  126. "Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery", J Cosnes, I Nion-Larmurier, L Beaugerie, P Afchain, E Tiret, and J-P Gendre. Gut 2005 Feb;54:237-241.
  127. "Traitement d'une maladie de Crohn œsophagienne par l'infliximab (Remicade®)", Jérôme Filippi, Pierre Mambrini, Kamel Arab, Stéphane M. Schneider, Xavier Hébuterne. Gastroenterol Clin Biol. 2005 Jan;29(1):84-5. (accès Gastroenterol Clin Biol - accès adhérents afa)

    2004

  128. "The murine Muc2 mucin gene is transcriptionally regulated by the zinc-finger GATA-4 transcription factor in intestinal cells", Maria van der Sluis, Monique H.M. Melis, Nicolas Jonckheere, Marie-Paule Ducourouble, Hans A. Büller, Ingrid Renes, Alexandra W.C. Einerhand and Isabelle Van Seuningen. Biochem Biophys Res Commun. 2004 Dec 17;325(3):952-960. (accès Biochem Biophys Res Commun - accès adhérents afa)
  129. "Crohn's disease over 20 years after diagnosis in a referral population", Etienney I, Bouhnik Y, Gendre JP, Lemann M, Cosnes J, Matuchansky C, Beaugerie L, Modigliani R, Rambaud JC. Gastroenterol Clin Biol. 2004 Dec;28(12):1233-9.
  130. "Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum", Thiefin G, Beaugerie L. Joint Bone Spine. 2005 Jul;72(4):286-94. Epub 2004 Nov 18.
  131. "Could Immunosuppressive Drugs Reduce Recurrence Rate After Second Resection for Crohn Disease?", Alves Arnaud, Panis Yves, Joly Francisca, Pocard Marc, Lavergne-Slove Anne, Bouhnik Yoram, Valleur Patrice. Inflamm Bowel Dis. 2004 Sept;10(5):481-495.
  132. "High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease", Arlette Darfeuille-Michaud, Jérôme Boudeau, Philippe Bulois, Christel Neut, Anne-Lise Glasser, Nicolas Barnich, Marie-Agnès Bringer, Alexander Swidsinski, Laurent Beaugerie, Jean-Frédéric Colombel. Gastroenterology 2004 Aug;127(2):412-21.
  133. "A phase III, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of antegren (Natalizumab) in maintaining clinical response and remission in Crohn's disease", Sandborn W, Colombel JF, Enns R, Feagan B, Hanauer S, Lawrance I, Panaccione R, Sanders M, Schreiber S, Targan S, Van Deventer S, Rutgeerts P. Gastroenterology 2004 Jul;127(1):132.
  134. "Crohn's disease in the over-60 age group: a population based study", Heresbach D, Alexandre JL, Bretagne JF, Cruchant E, Dabadie A, Dartois-Hoguin M, Girardot PM, Jouanolle H, Kerneis J, Le Verger JC, Louvain V, Pennognon L, Richecoeur M, Politis J, Robaszkiewicz M, Seyrig JA, Tron I; ABERMAD. Eur J Gastroenterol Hepatol. 2004 Jul;16(7):657-64.
  135. "Opposite evolution in incidence of Crohn’s disease and ulcerative colitis in Northern France (1988–1999)", AF Molinié, C Gower-Rousseau, T Yzet, V Merle, B Grandbastien, R Marti, E Lerebours, J-L Dupas, J-F Colombel, J-L Salomez and A Cortot. Gut 2004 Jun;53:843-848.
  136. "Probiotiques et maladies inflammatoires chroniques intestinales : à la conquête des pochites?", Alain Ledit, Bernard Duclos, René Baumann, Jean-Marie Reimund. Gastroenterol Clin Biol Juin 2004;28(6-7 cahier 1);619-624. (accès Gastroenterol Clin Biol - accès adhérents afa)
  137. "Clinical relevance of advances in genetics and pharmacogenetics of IBD", Tariq Ahmad, Cyrus Pesi Tamboli, Derek Jewell, Jean-Frédéric Colombel. Gastroenterology 2004 May;126(6):1533-49.
  138. "Involvement of Lipoprotein NlpI in the Virulence of Adherent Invasive Escherichia coli Strain LF82 Isolated from a Patient with Crohn's Disease", Nicolas Barnich, Marie-Agnès Bringer, Laurent Claret and Arlette Darfeuille-Michaud. Infect Immun 2004 May;72(5):2484-93.
  139. "Examens morphologiques au cours des MICI", Mourad Boudiaf, Philippe Soyer, Roland Rymer. Gastroenterol Clin Biol Mai 2004;28(sup. 5);46-51. (accès Gastroenterol Clin Biol - accès adhérents afa)
  140. "Imagerie des lésions ano-périnéales de la maladie de Crohn", Marc Barthet, Valérie Juhan, Mohamed Gasmi, Jean-Charles Grimaud. Gastroenterol Clin Biol Mai 2004;28(sup. 5);52-60. (accès Gastroenterol Clin Biol - accès adhérents afa)
  141. "Indications, effets indésirables des anti-TNF et mesures préventives", Perrine Cocq, Yazdan Yazdanpannah, Bruno Mesnard, Jean-Frédéric Colombel. Gastroenterol Clin Biol Mai 2004;28(sup. 5);61-69. (accès Gastroenterol Clin Biol - accès adhérents afa)
  142. "Prise en charge thérapeutique des proctites", Philippe Godeberge. Gastroenterol Clin Biol Mai 2004;28(sup. 5);70-74.
  143. "Lésions ostéo-articulaires au cours des maladies inflammatoires chroniques de l'intestin", Marc Lemann, Joëlle Bonnet, Matthieu Allez, Jean-Marc Gornet, Xavier Mariette. Gastroenterol Clin Biol. Mai 2004;28(sup. 5);75-82. (accès Gastroenterol Clin Biol - accès adhérents afa)
  144. "Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy", Colombel JF, Loftus EV Jr, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ. Am J Gastroenterol 2004 May;99(5):878-83.
  145. "Epstein-Barr virus viral load in Crohn's disease: effect of immunosuppressive therapy", Reijasse D, Le Pendeven C, Cosnes J, Dehee A, Gendre JP, Nicolas JC, Beaugerie L. Inflamm Bowel Dis. 2004 Mar;10(2):85-90.
  146. "Le risque de lymphome est-il accru par les immunosuppresseurs au cours des MICI? Le maillon manquant pour légitimer l'immunosuppression précoce", Laurent Beaugerie. Gastroenterol Clin Biol Mars 2004;28(3);218-220. (accès Gastroenterol Clin Biol - accès adhérents afa)
  147. "Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease", Louis E, El Ghoul Z, Vermeire S, Dall'Ozzo S, Rutgeerts P, Paintaud G, Belaiche J, De Vos M, Van Gossum A, Colombel JF, Watier H. Science. 2004 Apr 9;304(5668):242-8.
  148. "Bacterial invasion: the paradigms of enteroinvasive pathogens.", Cossart P, Sansonetti PJ. Aliment Pharmacol Ther 2004 Mar;19(5):511-9. Texte intégral.
  149. "Maladie de Crohn jéjuno-iléale : étude cas-témoins", Thierry Higuero, Corinne Merle, Gérard Thiéfin, Sylvie Coussinet, Damien Jolly, Marie-Danièle Diebold, Paul Zeitoun, Guillaume Cadiot. Gastroenterol Clin Biol 2004 ; 28 (2) ; 160-166 (accès Gastroenterol Clin Biol - résumé adhérents afa)
  150. "Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease", Rutgeerts P, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Hanauer SB. Gastroenterology 2004 Feb;126(2):402-13.
  151. "Renal impairment in patients with inflammatory bowel disease: association with aminosalicylate therapy?", Elseviers MM, D'Haens G, Lerebours E, Plane C, Stolear JC, Riegler G, Capasso G, Van Outryve M, Mishevska-Mukaetova P, Djuranovic S, Pelckmans P, De Broe ME. Clin Nephrol. 2004 Feb;61(2):83-9.
  152. "Transcriptional activation of the murine Muc5ac mucin gene in epithelial cancer cells by TGF-b/Smad4 signalling pathway is potentiated by Sp1", Jonckheere N, Van Der Sluis M, Velghe A, Buisine MP, Sutmuller M, Ducourouble MP, Pigny P, Buller HA, Aubert JP, Einerhand AW, Van Seuningen I. Biochem J. 2004 Feb 1;377(Pt 3):797-808.(accès Biochem Biophys Res Commun - accès adhérents afa)
  153. "The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients", Colombel JF, Loftus EV Jr, Tremaine WJ, Egan LJ, Harmsen WS, Schleck CD, Zinsmeister AR, Sandborn WJ. Gastroenterology. 2004 Jan;126(1):19-31.
  154. "Gender differences in the response of colitis to smoking", Cosnes J, Nion-Larmurier I, Afchain P, Beaugerie L, Gendre JP. Clin Gastroenterol Hepatol (United States), Jan 2004, 2(1) p41-8.
  155. "NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype- phenotype analysis", Heresbach D, Gicquel-Douabin V, Birebent B, D'halluin PN, Heresbach-Le Berre N, Dreano S, Siproudhis L, Dabadie A, Gosselin M, Mosser J, Semana G, Bretagne JF, Yaouanq J. Eur J Gastroenterol Hepatol. 2004 Jan;16(1):55-62.
  156. "Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents", Alexakis C, Caruelle JP, Sezeur A, Cosnes J, Gendre JP, Mosnier H, Beaugerie L, Gallot D, Malafosse M, Barritault D, Kern P. Gut 2004 Jan;53(1):85-90.
  157. "Dysbiosis in inflammatory bowel disease", Tamboli CP, Neut C, Desreumaux P, Colombel JF. Gut 2004 Jan;53(1):1-4.

    2003

  158. "Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing", Girardin SE, Hugot JP, Sansonetti PJ. Trends Immunol 2003 Dec;24(12):652-8.
  159. "Inflammation increases sufentanil requirements during surgery for inflammatory bowel diseases", Guidat A, Fleyfel M, Vallet B, Desreumaux P, Levron JC, Gambiez L, Colombel JF, Scherpereel P. Eur J Anaesthesiol. 2003 Dec;20(12):957-62.
  160. "A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis", Tilg H, Vogelsang H, Ludwiczek O, Lochs H, Kaser A, Colombel JF, Ulmer H, Rutgeerts P, Kruger S, Cortot A, D'Haens G, Harrer M, Gasche C, Wrba F, Kuhn I, Reinisch W. Gut 2003 Dec;52(12):1728-33.
  161. "Efficacité de la dilatation hydrostatique des sténoses anastomotiques de la maladie de Crohn", Eloi Blanchet, Philippe Beau. Gastroenterol Clin Biol Décembre 2003;27(12);1097-1099. (accès Gastroenterol Clin Biol - accès adhérents afa)
  162. "La 6-thioguanine peut causer des atteintes hépatiques sévères au cours des maladies inflammatoires cryptogénétiques de l'intestin (MICI)", B. Bonaz, X. Roblin. Gastroenterol Clin Biol Décembre 2003;27(12);1097-1099. (accès Gastroenterol Clin Biol - accès adhérents afa)
  163. "Leptine et maladies inflammatoires chroniques intestinale", Jean-Marie Reimund. Gastroenterol Clin Biol Novembre 2003;27(11);983-985. (accès Gastroenterol Clin Biol - accès adhérents afa)
  164. "Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases", Maryse Barbier, Hubert Vidal, Pierre Desreumaux, Laurent Dubuquoy, Arnaud Bourreille, Jean-François Colombel, Christine Cherbut, Jean-Paul Galmiche. Gastroenterol Clin Biol Novembre 2003;27(11);987-991.
  165. "Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine", Lecomte T, Contou JF, Beaugerie L, Carbonnel F, Cattan S, Gendre JP, Cosnes J. Dis Colon Rectum. 2003 Nov;46(11):1469-75.
  166. "A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation", Foussat A, Cottrez F, Brun V, Fournier N, Breittmayer JP, Groux H. J Immunol. 2003 Nov 15;171(10):5018-26.
  167. "Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2.", Girardin SE, Travassos LH, Herve M, Blanot D, Boneca IG, Philpott DJ, Sansonetti PJ, Mengin-Lecreulx D. J Biol Chem 2003 Oct 24;278(43):41702-8. Texte intégral.
  168. "Probiotics in inflammatory bowel disease: a critical review", Tamboli CP, Caucheteux C, Cortot A, Colombel JF, Desreumaux P. Best Pract Res Clin Gastroenterol 2003 Oct;17(5):805-20. Review.
  169. "Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice", Ferrier L, Mazelin L, Cenac N, Desreumaux P, Janin A, Emilie D, Colombel JF, Garcia-Villar R, Fioramonti J, Bueno L. Gastroenterology 2003 Sep;125(3):795-804.
  170. "Fermeture précoce des stomies du grêle", Pere Jordi-Galais, Nicolas Turrin, Christophe Tresallet, Quang Nguyen-Thanh, Jean-Paul Chigot, Fabrice Menegaux. Gastroenterol Clin Biol Août 2003;27(8-9);697-699.
  171. "Potential role of NKG2D/MHC class I-related chain A interaction in intrathymic maturation of single-positive CD8 T cells", Sophie Hüe, Renato C. Monteiro, Sonia Berrih-Aknin and Sophie Caillat-Zucman. J Immunol (United States), Aug 15 2003, 171(4) p1909-17.
  172. "Hydrostatic balloon dilatation of Crohn's strictures", Sabate JM, Villarejo J, Bouhnik Y, Allez M, Gornet JM, Vahedi K, Modigliani R, Lemann M. Aliment Pharmacol Ther Aug 15;18(4):409-13.
  173. "Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine",  Bonaz B, Boitard J, Marteau P, Lemann M, Coffin B, Flourie B, Belaiche J, Cadiot G, Metman EH, Cortot A, Colombel JF (GETAID). Aliment Pharmacol Ther. 2003 Aug 15;18(4):401-8.
  174. "Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease", Boudeau J, Glasser AL, Julien S, Colombel JF, Darfeuille-Michaud A. Aliment Pharmacol Ther 2003 Jul 1;18(1):45-56.
  175. "Flore intestinale et maladie de Crohn", Desreumaux P, Colombel JF. Ann Pharm Fr. 2003 Jul;61(4):276-81. Review.
  176. "Anti-Inflammatory Role for Intracellular Dimeric Immunoglobulin A by Neutralization of Lipopolysaccharide in Epithelial Cells" Fernandez MI, Pedron T, Tournebize R, Olivo-Marin JC, Sansonetti PJ, Phalipon A. Immunity. 2003 Jun;18(6):739-49.
  177. "What are the major arguments in favour of the genetic susceptibility for inflammatory bowel disease?" Tamboli CP, Cortot A, Colombel JF. Eur J Gastroenterol Hepatol 2003 Jun;15(6):587-92.
  178. "Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease", Cat H, Sophani I, Lemann M, Modiglani R, Solue JC, Turk J Gastroenterol 2003 Jun;14(2):121-7.
  179. "Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease", Barnich N, Boudeau J, Claret L, Darfeuille-Michaud A. Mol Microbiol 2003 May;48(3):781-94.
  180. "Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis", Dubuquoy L, Jansson EA, Deeb S, Rakotobe S, Karoui M, Colombel JF, Auwerx J, Pettersson S, Desreumaux P. Gastroenterology 2003 May;124(5):1265-76.
  181. "RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease.", Bourreille A, Doubremelle M, de la Bletiere DR, et al. Scand J Gastroenterol May 2003, 38(5) p526-32.
  182. "Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation", Philippe D, Dubuquoy L, Groux H, Brun V, Chuoi-Mariot MT, Gaveriaux-Ruff C, Colombel JF, Kieffer BL, Desreumaux P. J Clin Invest. 2003 May;111(9):1329-38. Texte intégral.
  183. "Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype", Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, El Yafi F, Colombel JF, Belaiche J. Gut 2003 Apr;52(4):460-1.
  184. "Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases.", Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, Bui TH, Giovannini M, Zaehringer U, Penard-Lacronique V, Sansonetti PJ, Hugot JP, Thomas G. Proc Natl Acad Sci USA 2003 Mar 18;100(6):3455-60. Texte intégral.
  185. "Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection", Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ. J Biol Chem 2003 Mar 14;278(11):8869-72.
  186. "Cyclooxygenase-2 expression and role of vasoconstrictor prostanoids in small mesenteric arteries from patients with Crohn's disease", Tabernero A, Reimund JM, Chasserot S, Muller CD, Andriantsitohaina R. Circulation (United States), Mar 18 2003, 107(10) p1407-10. Texte intégral.
  187. "Epidémiologie et histoire naturelle des MICI", Eric Lerebours, Guillaume Savoye, Claire Guédon. Gastroenterol Clin Biol. Mars 2003;27(sup3);76-80. (accès Gastroenterol Clin Biol - accès adhérents afa)
  188. "Physiopathologie des MICI : qu'en est-il des tests diagnostiques et prédictifs non invasifs?", Pierre Desrumaux, Arnaud Boureille, Jean-Frédéric Colombel. Gastroenterol Clin Biol Mars 2003;27(sup3);81-86. (accès Gastroenterol Clin Biol - accès adhérents afa)
  189. "Prise en charge médicale des MICI : les consensus et les controverses", Yoram Bouhnik. Gastroenterol Clin Biol Mars 2003;27(sup3);92-97. (accès Gastroenterol Clin Biol - accès adhérents afa)
  190. "Prise en charge chirurgicale des MICI : les consensus et les controverses", Yves Panis. Gastroenterol Clin Biol Mars 2003;27(sup3);98-103. (accès Gastroenterol Clin Biol - accès adhérents afa)
  191. "Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon", P Seksik, L Rigottier-Gois, G Gramet, M Sutren, P Pochart, P Marteau, R Jian, and J Doré. Gut. Feb 2003;52:237-242.
  192. "Clustering of Crohn's disease within affected sibships", Hugot JP, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, Montague S, Gassull M, Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Zouali H, Lesage S, Chamaillard M, Macry J, Thomas G, Victor JM (GETAID). Eur J Hum Genet. 2003 Feb;11(2):179-84.
  193. "CARD4/NOD1 is not involved in inflammatory bowel disease", Zouali H, Lesage S, Merlin F, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Christensen S, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Chamaillard M, Thomas G, Hugot JP; EPWG group; EPIMAD group. Gut 2003 Jan;52(1):71-4.
  194. "Faut-il réaliser une biopsie hépatique per-opératoire systématique chez tous les malades opérés pour rectocolite hémorragique?", Olivia Scalone, Cyril Bonaventure, Dominique Pasquier, Jean-Luc Faucheron. Gastroenterol Clin Biol Janvier 2003;27(1);94-99.

    2002

  195. "Rôle central du gène candidat pour la maladie de Crohn CARD15/Nod2 dans la susceptibilité aux infections bactériennes", Pierre Desrumaux. Gastroenterol Clin Biol Novembre 2002;26(11);1065-1066. (accès Gastroenterol Clin Biol - accès adhérents afa)
  196. "Etude d'un agrégat apparent de maladies de Crohn en Indre-et-Loire, 1990-1999", Valenciano M, Gagniere B, Maurage C, de Valk H, Desenclos JC. Rev Epidemiol Sante Publique. 2002 Dec;50(6):509-17.
  197. "Traitement de la maladie de Crohn par anticorps anti-TNF alpha (infliximab)", Marie Doubremelle, Arnaud Bourreille, Frank Zerbib, Denis Heresbach, Etienne Henry Metman, Philippe Beau, Jérôme Gournay, Jean-Paul Galmichev. Gastroenterol Clin Biol Novembre 2002;26(11);973-979. (accès Gastroenterol Clin Biol - accès adhérents afa)
  198. "Recommandations pour la prévention et la prise en charge de la tuberculose chez les patients sous infliximab", Salmon-Ceron D; Groupe recherche anti-TNF et infections opportunistes; Agence Francaise de Sécurite Sanitaire des Produits de Santé. Ann Med Interne (Paris). 2002 Nov;153(7):429-31.
  199. "Epithelial inflammation response induced by Shigella flexneri depends on mucin gene expression", Nutten S, Sansonetti P, Huet G, Bourdon-Bisiaux C, Meresse B, Colombel JF, Desreumaux P. Microbes Infect. 2002 Sep;4(11):1121-4.
  200. "Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease", Darfeuille-Michaud A. Int J Med Microbiol 2002 Sep;292(3-4):185-93.
  201. "Colites intercurrentes à Klebsiella oxytoca au cours de la maladie de Crohn", Aurélie Plessier, Jacques Cosnes, Jean-Pierre Gendre, Laurent Beaugerie. Gastroenterol Clin Biol Septembre 2002;26(8-9);799-800. (accès Gastroenterol Clin Biol - accès adhérents afa)
  202. "Long-term evolution of disease behavior of Crohn's disease", Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP. Inflamm Bowel Dis. 2002 Jul;8(4):244-50.
  203. "An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease", J. M. Sabate, J. Villarejo, M. Lemann, J. Bonnet, M. Allez & R. Modigliani. Aliment Pharmacol Ther Jun 2002, 16(6) p1117-24.
  204. "Le point sur les colites microscopiques", Stéphane M. Schneider, Patrick Rampal. Gastroenterol Clin Biol Mai 2002;26 (supplément 5);48-54. (accès Gastroenterol Clin Biol - accès adhérents afa)
  205. "Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial", Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P. Lancet. 2002 May 4;359(9317):1541-9.
  206. "The value of serologic markers in indeterminate colitis: a prospective follow-up study", Joossens S, Reinisch W, Vermeire S, Sendid B, Poulain D, Peeters M, Geboes K, Bossuyt X, Vandewalle P, Oberhuber G, Vogelsang H, Rutgeerts P, Colombel JF. Gastroenterology 2002 May;122(5):1242-7.
  207. "Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride", Abitbol V, Mary JY, Roux C, Soule JC, Belaiche J, Dupas JL, Gendre JP, Lerebours E, Chaussade S. Aliment Pharmacol Ther. 2002 May;16(5):919-27.
  208. "Lymphoepithelial interactions trigger specific regulation of gene expression in the M cell-containing follicle-associated epithelium of Peyer's patches", El Bahi S, Caliot E, Bens M, Bogdanova A, Kerneis S, Kahn A, Vandewalle A, Pringault E. J Immunol (United States), Apr 15 2002, 168(8) p3713-20. Texte intégral.
  209. "Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease", Neut C, Bulois P, Desreumaux P, Membre JM, Lederman E, Gambiez L, Cortot A, Quandalle P, van Kruiningen H, Colombel JF. Am J Gastroenterol 2002 Apr;97(4):939-46.
  210. "Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy", Allez M, Lemann M, Bonnet J, Cattan P, Jian R, Modigliani R. Am J Gastroenterol (United States), Apr 2002, 97(4) p947-53
  211. "Efficacité comparée de l'azathioprine dans la rectocolite hémorragique et dans la maladie de Crohn", Eric Kull, Philippe Beau. Gastroenterol Clin Biol 2002 Avril;26(4):367-371.
  212. "Epidemiology of inflammatory bowel diseases in the elderly in the province of Liège", Patricia Piront, Édouard Louis, Pascale Latour, Olivier Plomteux, Jacques Belaiche. Gastroenterol Clin Biol. 2002 Fevrier;26(2):157-161.
  213. "Rôle du gène NOD2 dans la maladie de Crohn", Jean-Pierre Hugot. Gastroenterol Clin Biol Janvier 2002;26(1):13-15. (accès Gastroenterol Clin Biol - accès adhérents afa)
  214. "CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease", Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP. OMIM Am J Hum Genet. 2002 Apr;70(4):845-57. Texte intégral.
  215. "Crohn's disease clinical course and severity in obese patients", Blain A, Cattan S, Beaugerie L, Carbonnel F, Gendre JP, Cosnes J. Clin Nutr. 2002 Feb;21(1):51-7.
  216. "Etude des répercussions psychologiques de deux modalités de traitement chez des adolescents atteints de maladie de Crohn", L. Gailhoustet, O. Goulet, N. Cachin and J. Schmitz. Arch Pédiatr. 2002 Feb;9(2):110-6.
  217. "Low ileal interleukin 10 concentrations are predictive of endoscopic recurrence in patients with Crohn's disease", Meresse B, Rutgeerts P, Malchow H, Dubucquoi S, Dessaint JP, Cohard M, Colombel JF, Desreumaux P. Gut 2002 Jan;50(1):25-8.
  218. "Le mycophénolate mofétil dans les formes chroniques actives de la maladie de Crohn après échec de l'azathioprine ou du méthotrexate", Hafraoui S, Dewit O, Marteau P, Cosnes J, Colombel JF, Modigliani R, Cortot A, Lemann M. Gastroenterol Clin Biol 2002 Jan;26(1):17-22.
  219. "Rôle du gène Nod2 dans la maladie de Crohn", Jean-Pierre Hugot. Gastroenterol Clin Biol. 2002 Jan;26(1):13-15. (accès Gastroenterol Clin Biol - accès adhérents afa).

    2001

  220. "Traitement par anticorps anti-TNFa (infliximab, Remicade®) des lésions anopérinéales de la maladie de Crohn", Atika Ouraghi, Sandrine Nieuviarts*, Jean-Luc Mougenel, Mathieu Allez, Marc Barthet, Franck Carbonnel, Jacques Cosnes, Jean-Pierre Gendre, Bernard Flourié, Jean-Jacques Meurisse, Pierre Quandalle, Olivier Ernst, Marc Lemann, Antoine Cortot, Robert Modigliani, Jean-Frédéric Colombel. Gastroenterol Clin Biol 2001 Nov;25(11):949-956. (accès Gastroenterol Clin Biol - accès adhérents afa)
  221. "Qu'attendre des thérapeutiques biologiques dans la maladie de Crohn?", Marc Lemann. Gastroenterol Clin Biol 2001 Nov;25(11):945-947. (accès Gastroenterol Clin Biol - accès adhérents afa)
  222. "Azathioprine for prevention of postoperative recurrence in Crohn's disease: a retrospective study", Cuillerier E, Lemann M, Bouhnik Y, Allez M, Rambaud JC,Modigliani R. Eur J Gastroenterol Hepatol (England), Nov 2001, 13(11) p1291-6
  223. "Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease?", Cornet A, Savidge TC, Cabarrocas J, Deng WL, Colombel JF, Lassmann H, Desreumaux P, Liblau RS. Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13306-11. Texte intégral.
  224. "Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease", Zouali H, Chamaillard M, Lesage S, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, Montague S, Gassull M, Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Macry J, Selinger-Leneman H, Thomas G, Hugot JP. Eur J Hum Genet. 2001 Oct 2001, 9(10) p731-42
  225. "Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients", Blondel-Kucharski F, Chircop C, Marquis P, Cortot A, Baron F, Gendre JP, Colombel JF. Am J Gastroenterol 2001 Oct;96(10):2915-20.
  226. "Mucin gene expression in intestinal epithelial cells in Crohn's disease", Buisine MP, Desreumaux P, Leteurtre E, Copin MC, Colombel JF, Porchet N, Aubert JP. Gut 2001 Oct;49(4):544-51.
  227. "Transcriptional regulation of the 11p15 mucin genes. Towards new biological tools in human therapy, in inflammatory diseases and cancer?", Van Seuningen I, Pigny P, Perrais M, Porchet N, Aubert JP. Front Biosci. 2001 Oct 1;6:D1216-34.
  228. "Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease", Zouali H, Chamaillard M, Lesage S, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, Montague S, Gassull M, Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Macry J, Selinger-Leneman H, Thomas G, Hugot JP. Related Articles, OMIM Eur J Hum Genet. 2001 Oct;9(10):731-42.
  229. "[Intestinal microflora and chronic inflammatory bowel diseases]", Desreumaux P, Colombel JF. Gastroenterol Clin Biol 2001 Sep;25 Spec No 2:C89-93. French. Pas de résumé.
  230. "An overview of regulatory T cells", Groux H. Microbes Infect. 2001 Sep;3(11):883-9.
  231. "Chronic use of non-steroidal anti-inflammatory drugs does not alter colonic mucosa of patients without diarrhoea", Beaugerie L, Berenbaum F, Berrebi D, Gendre JP, Prier A, Kaplan G, Chatelet FP. Aliment Pharmacol Ther. 2001 Sep;15(9):1301-6.
  232. "Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death", Glasser AL, Boudeau J, Barnich N, Perruchot MH, Colombel JF, Darfeuille-Michaud A. Infect Immun, 2001 Sep;69(9):5529-37.
  233. "Facteurs d'hyperhomocystéinémie au cours de la maladie de Crohn", Maire F, Beaugerie L, Cohen M, Deschamps A, Cosnes J, Capeau J, Gendre JP. Gastroenterol Clin Biol 2001 Aug-Sep;25(8-9):745-8.
  234. "Des rapports ambigus entre thrombose vasculaire et maladie de Crohn : coupable ? témoin ?", Gendre JP. Gastroenterol Clin Biol. 2001 Aug-Sep;25(8-9):743-4.
  235. "Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis", Jugde F, Alizadeh M, Boissier C, Chantry D, Siproudhis L, Corbinais S, Quelvennec E, Dyard F, Campion JP, Gosselin M, Bretagne JF, Semana G, Heresbach D. Eur Cytokine Netw 2001 Jul-Sep;12(3):468-77.
  236. "Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease", Sandborn WJ, Loftus EV Jr, Colombel JF, Fleming KA, Seibold F, Homburger HA, Sendid B, Chapman RW, Tremaine WJ, Kaul DK, Wallace J, Harmsen WS, Zinsmeister AR, Targan SR. Inflamm Bowel Dis. 2001 Aug;7(3):192-201.
  237. "Innate immune responses of epithelial cells following infection with bacterial pathogens", Philpott DJ, Girardin SE, Sansonetti PJ. Curr Opin Immunol 2001 Aug;13(4):410-6.
  238. "Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study", Annese V, Andreoli A, Andriulli A, Dinca R, Gionchetti P, Latiano A, Lombardi G, Piepoli A, Poulain D, Sendid B, Colombel JF. Am J Gastroenterol 2001 Aug;96(8):2407-12.
  239. "Impact of cessation of smoking on the course of ulcerative colitis", Beaugerie L, Massot N, Carbonnel F, Cattan S, Gendre JP, Cosnes J. Am J Gastroenterol 2001 Jul;96(7):2113-6.
  240. "Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease", Colombel JF, Rutgeerts P, Malchow H, Jacyna M, Nielsen OH, Rask-Madsen J, Van Deventer S, Ferguson A, Desreumaux P, Forbes A, Geboes K, Melani L, Cohard M. Gut 2001 Jul;49(1):42-6.
  241. "Traitement de la maladie de Crohn : riposte graduée ou traitement maximal d'emblée?", L. Beaugerie. Hépato-Gastro, 2001;2: 91-94. Texte intégral.
  242. "CD28+ intraepithelial lymphocytes with long telomeres are recruited within the inflamed ileal mucosa in Crohn disease", Meresse B, Dubucquoi S, Tourvieille B, Desreumaux P, Colombel JF, Dessaint JP. Hum Immunol. 2001 Jul;62(7):694-700.
  243. "Impact of cessation of smoking on the course of ulcerative colitis.", Beaugerie L, Massot N, Carbonnel F, Cattan S, Gendre JP, Cosnes J. Am J Gastroenterol July 2001 ; 96(7) : 2113-6.
  244. "Antibiotics in Crohn's disease", Colombel JF, Cortot A, van Kruiningen HJ. Gut 2001 May;48(5):647. Pas de résumé.
  245. "Devenir à l'âge adulte des enfants et des adolescents atteints de maladies inflammatoires chroniques de l'intestin", Seddik M, Turck D, Gottrand F, Colombel JF. Arch Pediatr. 2001 May;8 Suppl 2:221s-223s. Pas de résumé.
  246. "The importance of familial clusterings in Crohn's disease", Van Kruiningen HJ, Cortot A, Colombel JF. Inflamm Bowel Dis. 2001 May;7(2):170-3; discussion 174. Pas de résumé.
  247. "Association of Nod2 leucine-rich repeat variant with susceptibility to Crohn's disease", Hugot, J-P, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. Nature 411, 2001.
  248. "Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies", Desreumaux P, Dubuquoy L, Nutten S, Peuchmaur M, Englaro W, Schoonjans K, Derijard B, Desvergne B, Wahli W, Chambon P, Leibowitz MD, Colombel JF, Auwerx J. J Exp Med. 2001 Apr 2;193(7):827-38. Texte intégral.
  249. "Smoking cessation and the course of Crohn's disease: an intervention study", Cosnes J, Beaugerie L, Carbonnel F, Gendre JP. Gastroenterology 2001 Apr;120(5):1093-9.
  250. "Genetically related Escherichia coli strains associated with Crohn's disease", Masseret E, Boudeau J, Colombel JF, Neut C, Desreumeaux P, Joly B, Cortot A, Darfeuille-Michaud A. Gut 2001 Mar; 48: 320-325.
  251. "Inflammatory bowel disease in spouses and their offspring", Laharie D, Debeugny S, Peeters M, Van Gossum A, Gower-Rousseau C, Belaiche J, Fiasse R, Dupas JL, Lerebours E, Piotte S, Cortot A, Vermeire S, Grandbastien B, Colombel JF. Gastroenterology 2001 Mar;120(4):816-9.
  252. "Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells", Boudeau J, Barnich N, Darfeuille-Michaud A. Mol Microbiol 2001 Mar;39(5):1272-84.
  253. "Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003", Schreiber S, Campieri M, Colombel JF, van Deventer SJ, Feagan B, Fedorak R, Forbes A, Gassull M, Gendre JP, van Hogezand RA, Lofberg R, Modigliani R, Pallone F, Petritsch W, Prantera C, Rampton D, Seibold F, Vatn M, Zeitz M, Rutgeerts P. Int J Colorectal Dis. 2001 Feb;16(1):1-11; discussion 12-3.
  254. "Simple gas chromatography analysis of faecal butyrate: application to patients at risk of pouchitis", Clin Chem Lab Med. 2001 Jan;39(1):15-9.

    2000

  255. "Genetic analyses of chromosome 12 loci in Crohn's disease", S Lesage, H Zouali, J-F Colombel, J Belaiche, J-P Cézard, C Tysk, S Almer, M Gassull, V Binder, M Chamaillard, I Le Gall, G Thomas et J-P Hugot. Gut Dec 2000; 47: 787 - 791.
  256. "Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in ulcerative colitis (UC): no relationship with disease activity.", Reumaux D, Colombel JF, Masy E, Duclos B, Heresbach D, Belaiche J, Cortot A, Duthilleul P (GETAID). Inflamm Bowel Dis, Nov 2000, 6(4) p270-4.
  257. "T regulatory cells 1 inhibit a Th2-specific response in vivo.", Cottrez F, Hurst SD, Coffman RL, Groux H. J Immunol 2000 Nov 1;165(9):4848-53. Texte intégral.
  258. "Le récepteur activé par les proliférateurs des peroxysomes (PPAR) g : une nouvelle cible thérapeutique pour le traitement des maladies inflammatoires chroniques de l'intestin", Laurent Dubuquoy, Caroline Bourdon , Michel Peuchmaur, Mark D. Leibowitz , Sophie Nutten, Jean-Frédéric Colombel, Johan Auwerx, Pierre Desreumaux. Gastroenterol Clin Biol 2000 Sep; 24(8-9): 719-724. (accès Gastroenterol Clin Biol - accès adhérents afa)
  259. "Cytokine gene expression during postnatal small intestinal development: regulation by glucocorticoids", C Schaeffer, M Diab-Assef, M Plateroti, F Laurent-Huck, J M Reimund, M Kedinger et C Foltzer-Jourdainne. Gut Aug 2000; 47: 192 - 198.
  260. "Methotrexate in Crohn's disease: Long-term efficacy and toxicity.", Lémann M, Zenjari T, Bouhnik Y, Cosnes J, Mesnard B, Rambaud JC, Modigliani R, Cortot A, Colombel JF. Am J Gastroenterol July 2000 ; 95(7) : 1730-1734. (abstract)
  261. "Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy", Colombel JF, Ferrari N, Debuysere H, Marteau P, Gendre JP, Bonaz B, Soule JC, Modigliani R, Touze Y, Catala P, Libersa C, Broly F. Gastroenterology; June 2000 ; 118(6): 1025-30.
  262. "Rectocolite hémorragique : anastomose iléo-rectale ou iléo-anale?", Beaugerie L, Penna C. Gastroenterol Clin Biol 2000 Jul;24(5 Pt 2):B39-46.
  263.  "Gastrite granulomateuse. À propos de deux cas", Saint-Blancard P, Claude V, Roman F, Cointet F, Le Vagueresse R. Ann Pathol 2000 May;20(3):261-4.
  264. "Virus serology in familial Crohn disease", Van Kruiningen HJ, Mayo DR, Vanopdenbosch E, Gower-Rousseau C, Cortot A, Colombel JF. Scand J Gastroenterol. 2000 Apr;35(4):403-7.
  265. "Incidence des maladies inflammatoires du tube digestif chez l'enfant en Bretagne (1994-1997). Registre Abermad.", Tourtelier Y, Dabadie A, Tron I, Alexandre JL, Robaskiewicz M, Cruchant E, Seyrig JA, Heresbach D, Bretagne JF. Arch Pediatr 2000 Apr;7(4):377-84.
  266. "[Cheilitis granulomatosa in a child].", Olivier V, Lacour JP, Castanet J, Perrin C, Ortonne JP. Arch Pediatr 2000 Mar;7(3):274-7. French.
  267. "Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis", Carbonnel F, Gargouri D, Lemann M, Beaugerie L, Cattan S, Cosnes J, Gendre JP. Aliment Pharmacol Ther. 2000 Mar;14(3):273-9.
  268. "Prévalence de l'hépatite C chez les malades atteints d'une maladie inflammatoire chronique de l'intestin dans la région niçoise et évaluation des facteurs de risque", Longo F, Hebuterne X, Tran A, Staccini P, Hastier P, Schneider S, Benzaken S, Tirtaine C, Rampal P. Gastroenterol Clin Biol. 2000 Jan;24(1):77-81.

    1999

  269. "Aspects cliniques et évolutifs de la maladie de Crohn duodéno-jéjunale symptomatique", Christophe Andant, Béatrice Godeberge, Stanislas Chaussade, Jean-Louis Dupas, Jean-Claude Soulé. Gastroenterol Clin Biol 1999; 23: 1134 (accès Gastroenterol Clin Biol - accès adhérents afa)
  270. "Regulatory T cells and inflammatory bowel disease", Groux H, Powrie F. Immunol Today 1999 Oct;20(10):442-5.
  271. "Low levels of glutathione in endoscopic biopsies of patients with Crohn's colitis: the role of malnutrition", Miralles-Barrachina O, Savoye G, Belmonte-Zalar L,Hochain P, Ducrotte P,Hecketsweiler B, Lerebours E, Dechelotte P. Clin Nutr Oct 1999, 18(5) p313-7.
  272. "Le traitement de deuxième ligne de la RCH", Franck Carbonnel. Act Méd Int Gastroentérologie (13) n°7, septembre 1999. Texte intégral.
  273. "Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease", Boudeau J, Glasser AL, Masseret E, Joly B, Darfeuille-Michaud A. Infect Immun 1999; Sep;67(9):4499-509.
  274. "Maladie de Crohn jéjuno-iléale diffuse : une forme particulière de la maladie?", Ivan Touze, Corinne Gower-Rousseau, Bruno Grandbastien, Jean-Claude Paris, Pierre Quandalle, Antoine Cortot, Jean-Frédéric Colombel. Gastroenterol Clin Biol 1999; 23: 307-311 (accès Gastroenterol Clin Biol - accès adhérents afa)
  275. "Les anti-TNFa : un nouvel espoir dans le traitement de la MC", Jean-Frédéric Colombel. Hepato-Gastro vol 6, hors série mars 1999:1-2.Texte intégral.
  276. "Maladies inflammatoires chroniques de l'intestin et immunité", Stefan Schreiber. Hepato-Gastro vol 6, hors série mars 1999:16-25.Texte intégral.
  277. "Traitement de la maladie de Crohn par les anticorps monoclonaux anti-TNFa", Paul Rutgeerts, Jean-Frédéric Colombel. Hepato-Gastro vol 6, hors série mars 1999:26-30.Texte intégral.
  278. "Inflammatory alterations in mesenteric adipose tissue in Crohn's disease", Pierre Desreumaux, Olivier Ernst, Karel Geboes, Luc Gambiez, Dominique Berrebi, Heide MÜller-Alouf, Samira Hafraoui, Dominique Emilie, Nadine Ectors, Michel Peuchmaur, Antoine Cortot, Monique Capron, Johan Auwerx, Jean-Frédéric Colombel. Gastroenterology 1999; 117: 73-81.
  279. "Manifestations cutanéo-muqueuses extra-intestinales des maladies inflammatoires chroniques", Joëlle Bonnet, Marie-Estelle Roux, Michel Rybojad, Marc Lémann. Hépato-Gastro 1999; Mars-avril : vol. 2. Texte intégral.
  280. "A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID)", Colombel JF, Lemann M, Cassagnou M, et al. Am J Gastroenterol 1999; Mar;94(3):674-8.
  281. "Néphropathie interstitielle chronique grave liée à la maladie de Crohn et non à la prise de mésalazine?", Philippe Baumer, Jean-François Brocard, Wladimir Kohn, Pierre Bedossa, Bernard Charpentier. Gastroenterol Clin Biol 1999; 23: 1400-1402.Texte intégral.
  282. "Coût de la première prise en charge des maladies inflammatoires chroniques de l'intestin", Nathalie Rolland, Bruno Grandbastien, Véronique Merle, Corinne Gower-Rousseau, Thierry Yzet, Raymond Marti, Eric Lerebours, Jean-Louis Dupas, Pierre Czernichow, Jean-Louis Salomez, Thérèse Lebrun, Antoine Cortot. Gastroenterol Clin Biol 1999; 23: 483-488.Texte intégral.

    1998

  283. "Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease", Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, Gambiez L, Joly B, Cortot A, Colombel JF. Gastroenterol, 1998 Dec;115(6):1405-13.
  284. "Sous-populations lymphocytaires T immunorégulatrices et pathogénie des maladies ", Serge Jacquot. Hépato-Gastro 1998; Novembre-décembre : vol. 6.
  285. "Effet du tabac sur l'évolution à long terme de la rectocolite hémorragique", Mokbel M, Carbonnel F, Beaugerie L, Gendre JP, Cosnes J. Gastroenterol Clin Biol. 1998 Nov;22(11):858-62.
  286. "Interaction of microorganisms, epithelium, and lymphoid cells of the mucosa-associated lymphoid tissue", Hamzaoui N, Pringault E. Ann N Y Acad Sci 1998 Nov 17;859:65-74.
  287. "Intestinal Epithelial-Mesenchymal Cell Interactions", Kedinger M, Duluc I, Fritsch C, Lorentz O, Plateroti M, Freund JN. Ann N Y Acad Sci 1998 Nov 17;859:1-17.
  288. "Absence de détection d'ADN de Mycobacterium paratuberculosis et Mycobacteriumavium subsp. silvaticum par amplification génique dans la maladie de Crohn", Christophe Cellier, Hans De Beenhouwer, Anne Berger, Christophe Penna, Franck Carbonnel, Rolland Parc, Paul-Henri Cugnenc, Yves Le Quintrec, Jean-Pierre Gendre, Jean-Philippe Barbier, Françoise Portaels. Gastroenterol Clin Biol 1998; 22: 675-677 (accès Gastroenterol Clin Biol - résumé en français).
  289. "Mucin gene expression in human embryonic and fetal intestine", M P Buisine, L Devisme, T C Savidge, C Gespach, B Gosselin, N Porchet, and J P Aubert. Gut Oct 1998; 43: 519 - 524.
  290. "Physiopathologie et pathogénie des maladies inflammatoires chroniques intestinales", Bernard Duclos, Jean-Marie Reimund; Act. Méd. Int - Gastroentérologie (12), supplément au n°6 - Sept 1998.Texte intégral.
  291. "A comparison of budesonide and mesalamine for active Crohn's disease", International Budesonide-Mesalamine Study Group, Thomsen OØ; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E; N Engl J Med 1998 Aug 6.
  292. "Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease", Sendid B, Quinton JF, Charrier G, Goulet O, Cortot A, Grandbastien B, Poulain D, Colombel JF.Am J Gastroenterol 1998 Aug.
  293. "Etude de l'extension colique des maladies de Crohn iléales", Sylvie Pesghard , Franck Carbonnel, Laurent Beaugerie, Hélène D'Almagne Serrano, Fabrice Carrat, Jean-Pierre Gendre, Jacques Cosnes. Gastroenterol Clin Biol 1998; Jun-Jul 22(6-7):594 (accès Gastroenterol Clin Biol - accès adhérents afa)
  294. "New treatment for ileal pouch-anal or coloanal anastomotic stenosis", Benoist S; Panis Y; Berdah S; Hautefeuille P; Valleur P; Dis Colon Rectum 1998 Jul.
  295. "Mixed adenocarcinoid tumor and Crohn's disease", Auber F; Gambiez L; Desreumaux P; Mudry J; Lecomte-Houcke M; Cortot A; Quandalle P; Colombel JF; J Clin Gastroenterol 1998 Jun.
  296. "Les aspects du traitement chirurgical de la maladie de Crohn", Ch.L Thiry, A. Iderne, Ch. Meyer. Med Chir Dig 1998; 27 (4) : 137-141.Texte intégral.
  297. "Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromosome 16 (IBD1) to ulcerative colitis", Mirza MM; Lee J; Teare D; Hugot JP; Laurent-Puig P; Colombel JF; Hodgson SV; Thomas G; Easton DF; Lennard-Jones JE; Mathew CG; J Med Genet 1998 Mar; 35(3):218-21.
  298. "Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study", Marteau P; Crand J; Foucault M; Rambaud JC; Gut 1998 Feb;42:195-199.
  299. "Anticipation in familial Crohn's disease", Grandbastien B, Peeters M, Franchimont D, Gower-Rousseau C, Speckel D, Rutgeerts P, Bela¨,iche J, Cortot A, Vlietinck R, Colombel JF. Gut 1998 Feb; 42 (2):170-4.
  300. "Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis", Reimund JM, Allison AC, Muller CD, Dumont S, Kenney JS, Baumann R, Duclos B, Poindron P. Eur J Clin Invest 1998 Feb;28(2):145-50.
  301. "Dosage de la 6-mercaptopurine et étude des sous-populations lymphocytaires sanguines au cours du traitement par l'azathioprine dans la maladie de Crohn", Stéphane Cattan, Marc Lémann, François Thuillier, Djaouida Bengoufa, Claire Rabian, Yann Ngo, Yoram Bouhnik, Bernard Messing, Jean-Claude Rambaud, Robert Modigliani. Gastroenterol Clin Biol 1998; 22 (2): 160-167.
  302. "Colites graves chez l'enfant de moins de 3 ans", B Cuénod-Jabri, N Patey, D Turck, D Canioni, M Besnard, JF Mougenot, E Martin de Lassalle, JP Cézard, N Fékété, M Lecomte, N Broussea, V Colomba, C Ricoura et O Goulet. Arch Pédiatr. 1998 Fév;5(2):p224.
  303. "Thérapie combinée avec ciclosporine et azathioprine dans la recto-colite hémorragique sévère", B Papadatou, F Ferretti, M Gambarara, L Dall'Oglio, A Diamanti, F De Peppo et M Castro. Arch Pédiatr. 1998 Fév;5(2):p224.
  304. "Etude prospective de l'insulin growth factor (IGF1) dans la maladie de Crohn (MC) de l'enfant", V Varille, G Touati, M Noel, JP Hugo, M Besnard, C Faure, JP Cezard and J Navarro. Arch Pédiatr. 1998 Fév;5(2):227-228.
  305. "L'atteinte ano-périnéale au cours de la maladie de Crohn de l'enfant", MM Bellaiche, M Besnard, C Faure, JP Cézard, J Navarro et JF Mougenot. Arch Pédiatr. 1998 Jan;5(1):3-8.

    1997

  306. "Nitrate-reducing bacteria in diversion colitis: a clue to inflammation?", Neut C; Guillemot F; Colombel JF; Dig Dis Sci 1997 Dec.
  307. "Impact of surgery on quality of life in Crohn's disease", Yazdanpanah Y; Klein O; Gambiez L; Baron P; Desreumaux P; Marquis P; Cortot A; Quandalle P; Colombel JF; Am J Gastroenterol 1997 Oct.
  308. "Effects of an isotonic oral rehydration solution, enriched with glutamine, on fluid and sodium absorption in patients with a short-bowel", Beaugerie L; Carbonnel F; Hecketsweiler B; D´echelotte P; Gendre JP; Cosnes; Aliment Pharmacol Ther, 1997 Jul;11(4):741-6.
  309. "Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease", P Desreumaux, E Brandt, L Gambiez, D Emilie, K Geboes, O Klein, N Ectors, A Cortot, M Capron, and JF Colombel. Gastroenterol 1997 Jul; 113: 118-126.
  310. "Home parenteral nutrition in adults: a european multicentre survey in 1997. ESPEN-Home Artificial Nutrition Working Group", Bakker H, Bozzetti F, Staun M, Leon-Sanz M, Hebuterne X, Pertkiewicz M, Shaffer J, Thul P. Clin Nutr. 1999 Jun;18(3):135-40.
  311. "Changing intestinal connective tissue interactions alters homeobox gene expression in epithelial cells", Duluc I, Lorentz O, Fritsch C, Leberquier C, Kedinger M, Freund JN. J Cell Sci 1997 Jun;110( Pt 11):1317-1324.
  312. "[Morbid associations in Crohn's disease. Study of a series of 832 patients]", Beaugerie L, Lamy P, Ganne N, Carbonnel F, Le Quintrec Y, Cosnes J, Gendre JP. Presse Med. 1997 Jun 7;26(19):892-4. French.
  313. "Étude du polymorphisme des microsatellites et des gènes du tumor necrosis factor (TNF) au cours des maladies inflammatoires chroniques de l'intestin", Heresbach D; Abadou A; Bourienne A; Alizadeh M; Quelvennec E; Pagenault M; Dabadie A; Heresbach-Le Berre N; Campion JP; Launois B; Gosselin M; Génetet B; Bretagne JF; Sémana G; Gastroenterol Clin Biol 1997; 21 (8,9): 555-61.
  314. "In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease", Reimund JM; Dumont S; Muller CD; Kenney JS; Kedinger M; Baumann R; Poindron P; Duclos B; Gut 1997 Apr; 40(4): 475-480. Texte intégral.
  315. "Cytokines modulate fibroblast phenotype and epithelial-stroma interactions in rat intestine", Fritsch C, Simon-Assmann P, Kedinger M, Evans GS. Gastroenterology 1997 Mar; 112(3): 826-838.
  316. "Incidences des maladies inflammatoires chroniques de l'intestin, en France : le tableau s'enrichit", Gower-Rousseau C, Grandbastien B, Colombel JF, Cortot A. Gastroenterol Clin Biol 1997; 21(6-7): 481-482 (accès Gastroenterol Clin Biol - accès adhérents afa)
  317. "Incidence des maladies inflammatoires du tube digestif dans le département du Puy-de-Dôme en 1993 et 1994", Michel Flamenbaum, Marie Zenut, Bruno Aublet-Cuvelier, Jean-Luc Larpent, Philippe Fabre, le Groupe EPIMICI, Armand Abergel, Michel Dapoigny, Gilles Bommelaer. Gastroenterol Clin Biol 1997, Vol. 21, Fasc. 6.7, p. 491-496 (accès Gastroenterol Clin Biol - accès adhérents afa)
  318. "Incidence des maladies inflammatoires du tube digestif en Bretagne (1994-1995)", Mael Pagenault, Isabelle Tron, Jean-Luc Alexandre, Etienne Cruchant, Alain Dabadie, Jacques Chaperon, Michel Robaszkiewiecz, Jean-François Bretagne et ABERMAD. Gastroenterol Clin Biol 1997, Vol. 21, Fasc. 6.7, p. 483-490 (accès Gastroenterol Clin Biol - accès adhérents afa)
  319. "Effets indésirables de l'acide 5-aminosalicylique", Marteau P, Cellier C. Gastroenterol Clin Biol 1997; 21(5): 377-386 (accès Gastroenterol Clin Biol - accès adhérents afa)
  320. "Maladie de crohn ou anorexie mentale chez l'adolescent? Un piège diagnostic", MH Grandazzi, M Caflisch, M Duche and P Alvin. Arch Pédiatr. 1997 Feb;4(2 sup 2):p239.
  321. "L'interleukine-8 est un médiateur inflammatoire important au cours de la recto-colite hémorragique et de la maladie de Crohn", Jean-Marie Reimund, Bernard Duclos, Serge Dumont, Christian Muller, René Baumann, Philippe Poindron. Gastroenterol Clin Biol 1997, Vol. 21, Fasc. 2, p. 131-137.

    1996

  322. "Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease", Reimund JM, Wittersheim C, Dumont S, Muller CD, Kenney JS, Baumann R, Poindron P, Duclos B. Gut 1996 Nov;39(5):684-9
  323. "Clinical Characteristics of Crohn's Disease in 72 Families", JF Colombel, B Grandbastien, C Gower-Rousseau, S Plegat, JP Evrard, JL Dupas, JP Gendre, R Modigliani, J Belaiche, J Hostein, JP Hugot, H van Kruiningen et A Cortot. Gastroenterol 1996 111: 604-607
  324. "Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis", P Desreumaux, F Bloget, D Seguy, M Capron, A Cortot, JF Colombel, and A Janin. Gastroenterol 1996 110: 768-774.
  325. "Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID)", R Modigliani, JF Colombel, JL Dupas, M Dapoigny, V Costil, M Veyrac, B Duclos, JC Soule, JP Gendre, JP Galmiche, O Danne, G Cadiot, H Lamouliatte, J Belaiche, and JY Mary. Gastroenterol 1996; 110: 688-693.
  326. "Effects of cigarette smoking on the long-term course of Crohn's disease", J Cosnes, F Carbonnel, L Beaugerie, Y Le Quintrec, and JP Gendre. Gastroenterol 1996; 110: 424-431.
  327. "Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma", MP Buisine, A Janin, V Maunoury, JP Audie, MP Delescaut, MC Copin, JF Colombel, P Degand, JP Aubert, and N Porchet. Gastroenterol 1996 110: 84-91.
  328. "Coloscopie dans la maladie de Crohn : résultats reproductibles, mais d’une utilité douteuse", GETAID. Can J Gastroenterol 1996;10(6):405-412.
  329. "Association of HLA class II genes with susceptibility to Crohn's disease", Danze PM, Colombel JF, Jacquot S, Loste MN, Heresbach D, Ategbo S, Khamassi S, Perichon B, Semana G, Charron D, Cezard JP. Gut. 1996 Jul;39(1):69-72.
  330. "Fluorescence endoscopic imaging study of anastomotic recurrence of Crohn's disease" Maunoury V, Mordon S, Klein O, Colombel JF. Gastrointest Endosc 1996 Jun; 43(6): 603-604. No abstract available.
  331. "Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease.", Reimund JM, Wittersheim C, Dumont S, Muller CD, Baumann R, Poindron P, Duclos B. J Clin Immunol 1996May;16(3):144-50.
  332. "L'anastomose iléo-anale dans le maladie de Crohn", Panis Y; Poupard B; Nemeth J; Lavergne A; Hautefeuille P; Valleur P; Ann Gastroenterol Hepatol 1996 Mar-Apr.
  333. "[Genetics and chronic idiopathic inflammatory diseases of the intestines]", Reimund JM, Duclos B, Baumann R. Eur Ann Med Interne 1996;147(3):178-84.
  334. "Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease (GETAID)", Florent C, Cortot A, Quandale P, Sahmound T, Modigliani R, Sarfaty E, Valleur P, Dupas JL, Daurat M, Faucheron JL, Lerebours E, Michot F, Belaiche J, Jacquet N, Soule JC, Rothman N, Gendre JP, Malafosse M. Eur J Gastroenterol Hepatol 1996 Mar; 8(3): 229-233.
  335. "Mapping of a susceptibility locus for Crohn's disease on chromosome 16", Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas G. Nature 1996 Feb 29; 379(6568): 821-823.
  336. "Qualité de vie dans les maladies inflammatoires chroniques de l'intestin. Validation d'un questionnaire et premières données françaises", Jean-Frédéric Colombel, Yazdan Yazdpanpanah, Frédéric Laurent, Philippe Houcke, Nicolas Delas, Patrick Marquis. Gastroenterol Clin Biol 1996, Vol. 20, Fasc. 12, p. 1071-1077. Texte intégral.

    1995

  337. "Identifying patients with a high risk of relapse in quiescent Crohn's disease (GETAID)", Sahmoud T, Hoctin-Boes G, Modigliani R, Bitoun A, Colombel JF, Soule JC, Florent C, Gendre JP, Lerebours E, Sylvester R. Gut 1995 Dec; 37(6): 811-818.
  338. "[Type I hypersensitivity reactions and etiopathogenesis of hemorrhagic rectocolitis]", Leprince E; André C; Descos L; Presse Med. 1995 Dec 16-23.
  339. "[Genetics of inflammatory bowel diseases]", Hugot JP, Laurent-Puig P, Thomas G. Gastroenterol Clin Biol 1995 Nov; 19(11): 890-898. Review. French. No abstract available.
  340. "Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease", Dubucquoi S, Janin A, Klein O, Desreumaux P, Quandalle P, Cortot A, Capron M, Colombel JF. Gut 1995 Aug; 37(2): 242-246.
  341. "The relationship of granulomas to blood vessels in intestinal Crohn's disease", Matson AP, Van Kruiningen HJ, West AB, Cartun RW, Colombel JF, Cortot A. Mod Pathol 1995 Aug; 8(6): 680-685.
  342. "[Butyrate and hemorrhagic rectocolitis]", Flourié B; Descos L; Rambaud JC; Gastroenterol Clin Biol 1995, Jun-Jul.
  343. "Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease", Liu Y, van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Gastroenterology 1995 May; 108(5): 1396-1404.
  344. "[Rectocolite hemorragique et tabac]", Modigliani R. Rev Prat 1995, Apr 15;45(8):929-30.

    1994

  345. "Incidence of inflammatory bowel disease in northern France (1988-1990)", Gower-Rousseau C, Salomez JL, Dupas JL, Marti R, Nuttens MC, Votte A, Lemahieu M, Lemaire B, Colombel JF, Cortot A. Gut 1994 Oct; 35(10): 1433-1438.
  346. "Inflammatory bowel disease in married couples: 10 cases in Nord Pas de Calais region of France and Liege county of Belgium", Comes MC, Gower-Rousseau C, Colombel JF, Belaiche J, Van Kruiningen HJ, Nuttens MC, Cortot A. Gut 1994 Sep; 35(9): 1316-1318.
  347. "Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease (GETAID)", Hugot JP, Laurent-Puig P, Gower-Rousseau C, Caillat-Zucman S, Beaugerie L, Dupas JL, Van Gossum A, Bonait-Pellie C, Cortot A, Thomas G. Am J Med Genet 1994 Aug 15; 52(2): 207-213.
  348. "[Etiology of Crohn disease. Current data]", Colombel JF, Gower-Rousseau C. Presse Med 1994 Mar 26; 23(12): 558-560. Review. French.
  349. "Detection of Mycobacterium paratuberculosis by polymerase chain reaction in children with Crohn's disease", Dell'Isola B, Poyart C, Goulet O, Mougenot JF, Sadoun-Journo E, Brousse N, Schmitz J, Ricour C, Berche P. J Infect Dis 1994 Feb; 169(2): 449-451.

    1993

  350. "[Does Crohn's disease an infectious origin]?", Berche P. Arch Pediatr 1993 Dec; 50(10): 837-841. Review. French. No abstract available.
  351. "Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study (GETAID)", Gendre JP, Mary JY, Florent C, Modigliani R, Colombel JF, Soule JC, Galmiche JP, Lerebours E, Descos L, Viteau JM, et al. Gastroenterology 1993 Feb; 104(2): 435-439.
  352. "Que deviennent les colites aiguës inclassées? Résultats d'une étude de cohorte de 104 malades dans la région Nord-Pas-de-Calais", Notteghem B, Salomez JL, Gower-Rousseau C, Marti R, Lemahieu M, Nuttens MC, Dupas JL, Colombel JF, Cortot A. Gastroenterol Clin Biol 1993; 17(11): 811-815.

    1992

  353. "Subcorneal pustular dermatosis in a patient with Crohn's disease", Delaporte E, Colombel JF, Nguyen-Mailfer C, Piette F, Cortot A, Bergoend H. Acta Derm Venereol 1992 Aug; 72(4): 301-302.
  354. "Effect of intrajejunal elemental diet perfusion on jejunal secretion of immunoglobulins, albumin, and hyaluronan in man", Colombel JF, Vaerman JP, Hallgren R, Dehennin JP, Wain E, Modigliani R, Cortot A. Gut 1992 Jan; 33(1): 44-47.

    1991

  355. "Epidémiologie et génétique des maladies inflammatoires du tube digestif", Cortot A, Gower-Rousseau C, Colombel JF. Rev Prat 1991 Feb 11; 41(5): 393-396. Review. French.
  356. "[Incidence of inflammatory bowel diseases in children in the Nord-Pas-de-Calais region]", Gottrand F, Colombel JF, Moreno L, Salomez JL, Farriaux JP, Cortot A. Arch Pediatr 1991 Jan; 48(1): 25-28.

    1990

  357. "Incidence des maladies inflammatoires du tube digestif dans la région Nord-Pas de Calais et le département de la Somme (1988)", Colombel JF, Dupas JL, Cortot A, Salomez JL, Marti R, Gower-Rousseau C, Capron-Chivrac D, Lerebours E, Czernichow B, Paris JC. Gastroenterol Clin Biol 1990; 14(8-9): 614-618. French.
     
  358. "Testing for course patterns in Crohn's disease using clustering analysis", Beaugerie L, Le Quintrec Y, Paris JC, Godchaux JM, Saint-Raymond A, Schmitz J, Ricour C, Haddak M, Diday E. Gastroenterol Clin Biol 1989 Dec; 13(12): 1036-1041.
  359. "Crohn's disease in a married couple and their four children", Darchis I, Colombel JF, Cortot A, Devred M, Paris JC. Lancet 1989 Apri1; 1(8640): 737.

    1987

  360. "Le Vécu de la Maladie de Crohn. Etude par questionnaire", Bellanger J; Le Quintrec Y; Alle JP. Ann Gastroenterol Hepatol 1987; 23, n°4, 221-227. Texte intégral.
     
Retour à la page d'accueil
Vos questions ou commentaires sont les bienvenus.

sur tout le site.
Dernière mise à jour : 12/02/2008

© Association François Aupetit, 1997-2008